152 related articles for article (PubMed ID: 30522964)
21. PPARγ: A turning point for irritable bowel syndrome treatment.
Roudsari NM; Lashgari NA; Zandi N; Pazoki B; Momtaz S; Sahebkar A; Abdolghaffari AH
Life Sci; 2020 Sep; 257():118103. PubMed ID: 32681913
[TBL] [Abstract][Full Text] [Related]
22. Dietary Marine n-3 PUFAs Do Not Affect Stress-Induced Visceral Hypersensitivity in a Rat Maternal Separation Model.
van Diest SA; van den Elsen LW; Klok AJ; Welting O; Hilbers FW; van de Heijning BJ; Gaemers IC; Boeckxstaens GE; Werner MF; Willemsen LE; de Jonge WJ; van den Wijngaard RM
J Nutr; 2015 May; 145(5):915-22. PubMed ID: 25716554
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats.
Róka R; Ait-Belgnaoui A; Salvador-Cartier C; Garcia-Villar R; Fioramonti J; Eutamène H; Bueno L
Gut; 2007 Aug; 56(8):1072-8. PubMed ID: 17309885
[TBL] [Abstract][Full Text] [Related]
24. TLR4 upregulates CBS expression through NF-κB activation in a rat model of irritable bowel syndrome with chronic visceral hypersensitivity.
Yuan B; Tang WH; Lu LJ; Zhou Y; Zhu HY; Zhou YL; Zhang HH; Hu CY; Xu GY
World J Gastroenterol; 2015 Jul; 21(28):8615-28. PubMed ID: 26229403
[TBL] [Abstract][Full Text] [Related]
25. EphrinB2/ephB2 activation facilitates colonic synaptic potentiation and plasticity contributing to long-term visceral hypersensitivity in irritable bowel syndrome.
Zhang L; Wang R; Chen Y; Yang P; Bai T; Song J; Hou X
Life Sci; 2022 Apr; 295():120419. PubMed ID: 35183555
[TBL] [Abstract][Full Text] [Related]
26. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
Yu ZC; Cen YX; Wu BH; Wei C; Xiong F; Li DF; Liu TT; Luo MH; Guo LL; Li YX; Wang LS; Wang JY; Yao J
World J Gastroenterol; 2019 Aug; 25(29):3956-3971. PubMed ID: 31413530
[TBL] [Abstract][Full Text] [Related]
27. The comprehensive pathophysiological changes in a novel rat model of postinflammatory visceral hypersensitivity.
Ma J; Li J; Qian M; He N; Cao Y; Liu Y; Wu K; He S
FASEB J; 2019 Dec; 33(12):13560-13571. PubMed ID: 31570003
[TBL] [Abstract][Full Text] [Related]
28. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
[TBL] [Abstract][Full Text] [Related]
29. Calcium Pyruvate Exerts Beneficial Effects in an Experimental Model of Irritable Bowel Disease Induced by DCA in Rats.
Rodríguez-Nogales A; Algieri F; Vezza T; Garrido-Mesa J; Molina-Tijeras JA; Rodríguez-Cabezas ME; Utrilla MP; Pischel I; Gálvez J
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30634696
[TBL] [Abstract][Full Text] [Related]
30. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
Shamshiri H; Paragomi P; Paydar MJ; Moezi L; Bahadori M; Behfar B; Ardalan FA; Dehpour AR
J Gastroenterol Hepatol; 2009 Apr; 24(4):672-80. PubMed ID: 19032458
[TBL] [Abstract][Full Text] [Related]
31. Imeglimin prevents visceral hypersensitivity and colonic hyperpermeability in irritable bowel syndrome rat model.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
J Pharmacol Sci; 2023 Sep; 153(1):26-30. PubMed ID: 37524451
[TBL] [Abstract][Full Text] [Related]
32. Spinal neuroimmune activation inhibited by repeated administration of pioglitazone in rats after L5 spinal nerve transection.
Jia HB; Wang XM; Qiu LL; Liu XY; Shen JC; Ji Q; Yang JJ
Neurosci Lett; 2013 May; 543():130-5. PubMed ID: 23583338
[TBL] [Abstract][Full Text] [Related]
33. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P.
Yin Y; Zhong L; Wang JW; Zhao XY; Zhao WJ; Kuang HX
World J Gastroenterol; 2015 Apr; 21(15):4536-46. PubMed ID: 25914462
[TBL] [Abstract][Full Text] [Related]
34. Peripheral contribution of NGF and ASIC1a to colonic hypersensitivity in a rat model of irritable bowel syndrome.
Matricon J; Muller E; Accarie A; Meleine M; Etienne M; Voilley N; Busserolles J; Eschalier A; Lazdunski M; Bourdu S; Gelot A; Ardid D
Neurogastroenterol Motil; 2013 Nov; 25(11):e740-54. PubMed ID: 23902154
[TBL] [Abstract][Full Text] [Related]
35. 5-HT(2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction.
O'Mahony SM; Bulmer DC; Coelho AM; Fitzgerald P; Bongiovanni C; Lee K; Winchester W; Dinan TG; Cryan JF
Neurogastroenterol Motil; 2010 May; 22(5):573-8, e124. PubMed ID: 20003079
[TBL] [Abstract][Full Text] [Related]
36. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats.
Winston J; Shenoy M; Medley D; Naniwadekar A; Pasricha PJ
Gastroenterology; 2007 Feb; 132(2):615-27. PubMed ID: 17258716
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Potential of RET Kinase Inhibition for Irritable Bowel Syndrome: A Preclinical Investigation in Rodent Models of Colonic Hypersensitivity.
Russell JP; Mohammadi E; Ligon CO; Johnson AC; Gershon MD; Rao M; Shen Y; Chan CC; Eidam HS; DeMartino MP; Cheung M; Oliff AI; Kumar S; Greenwood-Van Meerveld B
J Pharmacol Exp Ther; 2019 Feb; 368(2):299-307. PubMed ID: 30413627
[TBL] [Abstract][Full Text] [Related]
38. P2X receptor-mediated visceral hyperalgesia in a rat model of chronic visceral hypersensitivity.
Xu GY; Shenoy M; Winston JH; Mittal S; Pasricha PJ
Gut; 2008 Sep; 57(9):1230-7. PubMed ID: 18270243
[TBL] [Abstract][Full Text] [Related]
39. Influence of simethicone and alverine on stress-induced alterations of colonic permeability and sensitivity in rats: beneficial effect of their association.
Bueno L; Beaufrand C; Theodorou V; Andro-Delestrain MC
J Pharm Pharmacol; 2013 Apr; 65(4):567-73. PubMed ID: 23488786
[TBL] [Abstract][Full Text] [Related]
40. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity
Boulete IM; Thadi A; Beaufrand C; Patwa V; Joshi A; Foss JA; Eddy EP; Eutamene H; Palejwala VA; Theodorou V; Shailubhai K
World J Gastroenterol; 2018 May; 24(17):1888-1900. PubMed ID: 29740204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
